000276094 001__ 276094
000276094 005__ 20250126000541.0
000276094 0247_ $$2doi$$a10.1001/jamaneurol.2024.3828
000276094 0247_ $$2pmid$$apmid:39527036
000276094 0247_ $$2ISSN$$a2168-6149
000276094 0247_ $$2ISSN$$a0003-9942
000276094 0247_ $$2ISSN$$a0375-8540
000276094 0247_ $$2ISSN$$a1538-3687
000276094 0247_ $$2ISSN$$a2168-6157
000276094 0247_ $$2ISSN$$a2330-9644
000276094 0247_ $$2altmetric$$aaltmetric:170981134
000276094 037__ $$aDZNE-2025-00175
000276094 041__ $$aEnglish
000276094 082__ $$a610
000276094 1001_ $$0P:(DE-2719)9001249$$aWagemann, Olivia$$b0$$eFirst author$$udzne
000276094 245__ $$aGantenerumab in Dominantly Inherited Alzheimer Disease-Reply.
000276094 260__ $$aChicago, Ill.$$bAmerican Medical Association$$c2025
000276094 3367_ $$2DRIVER$$aarticle
000276094 3367_ $$2DataCite$$aOutput Types/Journal article
000276094 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1737454707_5211$$xLetter
000276094 3367_ $$2BibTeX$$aARTICLE
000276094 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000276094 3367_ $$00$$2EndNote$$aJournal Article
000276094 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000276094 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000276094 7001_ $$aMcDade, Eric$$b1
000276094 7001_ $$aBateman, Randall J$$b2
000276094 773__ $$0PERI:(DE-600)2701924-X$$a10.1001/jamaneurol.2024.3828$$gVol. 82, no. 1, p. 111 -$$n1$$p111$$tJAMA neurology$$v82$$x2168-6149$$y2025
000276094 7870_ $$0DZNE-2024-00567$$aWagemann, Olivia et.al.$$dChicago, Ill. : American Medical Association, 2024$$iRelatedTo$$r$$tDownstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease
000276094 909CO $$ooai:pub.dzne.de:276094$$pVDB
000276094 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001249$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000276094 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000276094 9141_ $$y2025
000276094 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-27
000276094 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-27
000276094 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-27
000276094 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-27
000276094 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-27
000276094 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-27
000276094 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-27
000276094 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-27
000276094 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-27
000276094 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-27
000276094 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJAMA NEUROL : 2022$$d2024-12-27
000276094 915__ $$0StatID:(DE-HGF)9925$$2StatID$$aIF >= 25$$bJAMA NEUROL : 2022$$d2024-12-27
000276094 9201_ $$0I:(DE-2719)1111015$$kClinical Research (Munich)$$lClinical Research (Munich)$$x0
000276094 980__ $$ajournal
000276094 980__ $$aVDB
000276094 980__ $$aI:(DE-2719)1111015
000276094 980__ $$aUNRESTRICTED